Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
NFL Commissioner Roger Goodell confidently strides to the podium, opens an envelope and intones, “With the number one pick in the 2014 NFL draft, the Houston Texans select ' ” Millions of eyes watched the latest NFL draft to see players picked by different teams and to critique those choices. Truth is, millions of dollars and reputations are at stake in making sound selection decisions.
In this respect, the NFL draft has much in common with selecting defense counsel in medical malpractice cases. Like any NFL franchise, the physician and medical malpractice insurer want to make sure that they make sound “first-round draft picks.” These picks can be successful or they can be a bust. Making bone-headed selections can cost millions of dollars in professional reputations if an attorney ends up mishandling a medical malpractice case.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.